Walgreen Anti Nausea Solution
NDC Package 0363-7080-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Walgreen Anti Nausea (phosphorated carbohydrate) solution is ▪for maximum effectiveness never dilute or drink fluids of any kind immediately before or after taking this product▪repeat dose every 15 minutes or until distress subsides▪do not take more than 5 doses in 1 hour without consulting a doctor▪measure only with dosing cup provided. This formulation utilizes a solution delivery system. Marketed by Walgreens Co., this product is identified by NDC 0363-7080.

Identification & Billing

NDC Package Code
0363-7080-04
Package Description
1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
00363708004
RxNorm Crosswalk
  • RxCUI: 318146 - dextrose 1.87 GM / fructose 1.87 GM / phosphoric acid 21.5 MG in 5 mL Oral Solution
  • RxCUI: 318146 - fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution
  • RxCUI: 318146 - dextrose 1.87 GM / fructose 1.87 GM / phosphoric acid 21.5 MG per 5 ML Oral Solution

Clinical Specifications

Proprietary Name
Walgreen Anti Nausea Cherry Flavor
Non-Proprietary Name
Phosphorated Carbohydrate
Substance Name
Dextrose, Unspecified Form; Fructose; Phosphoric Acid
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
▪for maximum effectiveness never dilute or drink fluids of any kind immediately before or after taking this product▪repeat dose every 15 minutes or until distress subsides▪do not take more than 5 doses in 1 hour without consulting a doctor▪measure only with dosing cup provided. Dosing cup to be used with product only. Do not use with other products.▪mL = millilitersAgeDoseAdults and children 12 years of age and over15 mL or 30 mLChildren 2 to under 12 years of age5 mL or 10 mL

Regulatory & Marketing

Labeler Name
Walgreens Co.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
10-16-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0363-7080-04 identifies a specific commercial package of 1 bottle in 1 carton / 118 ml in 1 bottle of Walgreen Anti Nausea Cherry Flavor, a human over the counter drug labeled by Walgreens Co.. This solution is formulated for oral use and contains dextrose, unspecified form; fructose; phosphoric acid as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Walgreens Co. on October 16, 2023. The current certification is valid through December 31, 2026.

How is this Walgreens Co. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00363708004. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0363-7080-04
11-Digit CMS (5-4-2)
00363-7080-04

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.